January 2014 FDA Recall Drug by Mylan Institutional, Inc. (d.b.a. Udl Laboratories) (D-1155-2014 - Failed Impurity/degradation Specification)

This Class III drug recall was voluntarily initiated by Mylan Institutional, Inc. (d.b.a. Udl Laboratories) on January 28, 2014 for the product Drug. The FDA reported the reason for recall as failed impurity/degradation specification. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1155-2014

Reason for Recall
Failed Impurity/degradation Specification
Initiated
01-28-2014
Reported
03-19-2014
Quantity
3,252 cartons

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Mylan Institutional, Inc. (d.b.a. UDL Laboratories)
Carisoprodol Tablets, USP, 350 mg, unit dose blister packages of 100 tablets (10 cards of 10 tablets each), Rx only, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL NDC 51079-819-20

Batch or Lot Expiration Information

Lot# Lots and Expiration Dates: 3037463, Expires 2/2014; 3039466, Expires 3/2014; 3040644, Expires 4/2014; 3043463, Expires 6/2014; 3049568, Expires 3/2015